This may be the first SPAC to essentially merge with itself, but it will most assuredly not be the last.
If he’s got to do seven years for jacking up a drug’s price, he’s gonna make damned sure it stays jacked up.
Those 10b5-1 sales sure were preset perfectly for a pandemic.
You know, those halcyon days of last week.
Oh, there was also some alleged insurance fraud going on in the opioid-pushing.
Rep. Chris Collins should have just started a hedge fund.
The company, whose FDA-approved products include the myeloma drug Darzalex and the chronic leukemia drug Arzerra, hopes to launch its own proprietary product by 2025.
We can taste this one it's so perfect.
Giving a thinly-veiled anonymous interview on a contraband cellphone to brag about how he is illegally running a pharma business from prison reminds us why we miss this guy.
This even applies to pharma apparently.
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Valeant really Herbalife'd old Billy.
How do you put a price on failure?
Fun with pharma stocks and irony!
Heather Bresch seems to have known that Heather Bresch's management was going to have an adverse effect on Mylan stock.
That brings Martin's grand total to eight...so far.